Lonza board boots CEO Borgas

Pressure from Asian low-cost chemical and drug ingredient suppliers, combined with high Swiss energy costs impacting manufacturing operations, have yielded poor financial performance at Lonza and the ouster of CEO Stefan Borgas. "Our decision to replace Borgas was made during the past 48 hours and is backed by the board and management," said board chairman and acting-CEO Rolf Soiron. Story